Diabetes, Vol 48, Issue 4 766-774, Copyright © 1999 by American Diabetes Association

ARTICLES

Free fatty acids impair hepatic insulin extraction in vivo

SR Wiesenthal, H Sandhu, RH McCall, V Tchipashvili, H Yoshii, K Polonsky, ZQ Shi, GF Lewis, A Mari and A Giacca
Department of Physiology, University of Toronto, Ontario, Canada.

Hyperinsulinemia is a common finding in obesity and results from insulin hypersecretion and impaired hepatic insulin extraction. In vitro studies have shown that free fatty acids (FFAs), which are often elevated in obesity, can impair insulin binding and degradation in isolated rat hepatocytes. To investigate whether FFAs impair hepatic insulin extraction (E(H)) in vivo, either saline (SAL) or 10% Intralipid (0.03 ml x kg(-1) x min(-1)) plus heparin (0.44 U x kg(-1) x min(-1)) (IH) was infused into normal dogs to elevate FFA levels. Insulin was infused intraportally at 18 pmol x kg(-1) x min(-1) for 150 min (period A, high insulin dose), and then at 2.4 pmol x kg(-1) x min(-1) for another 150 min (period B, low insulin dose). After the low portal insulin dose, additional insulin was infused peripherally at 8.4 pmol x kg(-1) x min(-1) for 120 min (period C) to assess the clearance of insulin from the peripheral plasma. In 16 paired experiments, FFA levels were 1,085 +/- 167, 1,491 +/- 240, 1,159 +/- 221 micromol/l (IH) and 221 +/- 44, 329 +/- 72, 176 +/- 44 micromol/l (SAL) in periods A, B, and C, respectively. Peripheral insulin levels were greater with IH (P < 0.001) than with SAL in all periods (1,620 +/- 114, 126 +/- 12, 1,050 +/- 72 pmol/l for IH vs. 1,344 +/- 168, 96 +/- 4.2, 882 +/- 60 pmol/l for SAL). Glucose clearance was impaired by IH in all periods (P < 0.05), whereas glucose production was slightly increased by IH during period B. Peripheral insulin clearance (Cl) and E(H) were calculated from the insulin infusion rate and insulin concentration data in each period by taking into account the nonlinearity of insulin kinetics. Cl was lower (P < 0.01) with IH (9.6 +/- 0.6, 12.0 +/- 0.9, 10.2 +/- 0.6 ml x kg(-1) x min(-1)) than with SAL (11.2 +/- 1, 13.6 +/- 0.7, 11.9 +/- 0.9 ml x kg(-1) x min(-1)) in periods A, B, and C. E(H) was also lower (P < 0.05) with IH (25 +/- 4, 40 +/- 5, 32 +/- 5%) than with SAL (30 +/- 2.8, 47 +/- 3, 38 +/- 3%). We conclude that FFAs can impair hepatic insulin extraction in vivo at high and low insulin levels, an effect that may contribute to the peripheral hyperinsulinemia of obesity.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. H. Nelson, R. Basu, C. M. Johnson, R. A. Rizza, and J. M. Miles Splanchnic Spillover of Extracellular Lipase Generated Fatty Acids in Overweight and Obese Humans Diabetes, December 1, 2007; 56(12): 2878 - 2884. [Abstract] [Full Text] [PDF]

				S. P. Kim, K. J. Catalano, I. R. Hsu, J. D. Chiu, J. M. Richey, and R. N. Bergman Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1590 - E1598. [Abstract] [Full Text] [PDF]

				S. P. Kim, M. Ellmerer, E. L. Kirkman, and R. N. Bergman beta-Cell "rest" accompanies reduced first-pass hepatic insulin extraction in the insulin-resistant, fat-fed canine model Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1581 - E1589. [Abstract] [Full Text] [PDF]

				H.-Y. Liu, Q. F. Collins, Y. Xiong, F. Moukdar, E. G. Lupo Jr., Z. Liu, and W. Cao Prolonged Treatment of Primary Hepatocytes with Oleate Induces Insulin Resistance through p38 Mitogen-activated Protein Kinase J. Biol. Chem., May 11, 2007; 282(19): 14205 - 14212. [Abstract] [Full Text] [PDF]

				Q. F. Collins, Y. Xiong, E. G. Lupo Jr., H.-Y. Liu, and W. Cao p38 Mitogen-activated Protein Kinase Mediates Free Fatty Acid-induced Gluconeogenesis in Hepatocytes J. Biol. Chem., August 25, 2006; 281(34): 24336 - 24344. [Abstract] [Full Text] [PDF]

				D. J. Jenkins, A. R Josse, R. Labelle, A. Marchie, L. S. Augustin, and C. W. Kendall Nonalcoholic fatty liver, nonalcoholic steatohepatitis, ectopic fat, and the glycemic index Am. J. Clinical Nutrition, July 1, 2006; 84(1): 3 - 4. [Full Text] [PDF]

				H. Yoshii, T. K. T. Lam, N. Gupta, T. Goh, C. A. Haber, H. Uchino, T. T. Y. Kim, V. Z. Chong, K. Shah, I. G. Fantus, et al. Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1089 - E1097. [Abstract] [Full Text] [PDF]

				T. T. Tran, D. Naigamwalla, A. I. Oprescu, L. Lam, G. McKeown-Eyssen, W. R. Bruce, and A. Giacca Hyperinsulinemia, But Not Other Factors Associated with Insulin Resistance, Acutely Enhances Colorectal Epithelial Proliferation in Vivo Endocrinology, April 1, 2006; 147(4): 1830 - 1837. [Abstract] [Full Text] [PDF]

				M. Kabir, K. J. Catalano, S. Ananthnarayan, S. P. Kim, G. W. Van Citters, M. K. Dea, and R. N. Bergman Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E454 - E461. [Abstract] [Full Text] [PDF]

				R. M. van Dam, W. J. Pasman, and P. Verhoef Effects of Coffee Consumption on Fasting Blood Glucose and Insulin Concentrations: Randomized controlled trials in healthy volunteers Diabetes Care, December 1, 2004; 27(12): 2990 - 2992. [Full Text] [PDF]

				J. Gao, L. Ghibaudi, and J. J. Hwa Selective activation of central NPY Y1 vs. Y5 receptor elicits hyperinsulinemia via distinct mechanisms Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E706 - E711. [Abstract] [Full Text] [PDF]

				P. D. Dworatzek, R. A Hegele, and T. M. Wolever Postprandial lipemia in subjects with the threonine 54 variant of the fatty acid-binding protein 2 gene is dependent on the type of fat ingested Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1110 - 1117. [Abstract] [Full Text] [PDF]

				M. Hawkins, J. Tonelli, P. Kishore, D. Stein, E. Ragucci, A. Gitig, and K. Reddy Contribution of Elevated Free Fatty Acid Levels to the Lack of Glucose Effectiveness in Type 2 Diabetes Diabetes, November 1, 2003; 52(11): 2748 - 2758. [Abstract] [Full Text] [PDF]

				S. Kashyap, R. Belfort, A. Gastaldelli, T. Pratipanawatr, R. Berria, W. Pratipanawatr, M. Bajaj, L. Mandarino, R. DeFronzo, and K. Cusi A Sustained Increase in Plasma Free Fatty Acids Impairs Insulin Secretion in Nondiabetic Subjects Genetically Predisposed to Develop Type 2 Diabetes Diabetes, October 1, 2003; 52(10): 2461 - 2474. [Abstract] [Full Text] [PDF]

				C.J.M. Halkes, H. van Dijk, C. Verseyden, P.P.Th. de Jaegere, H.W.M Plokker, S. Meijssen, D.W. Erkelens, and M. C. Cabezas Gender Differences in Postprandial Ketone Bodies in Normolipidemic Subjects and in Untreated Patients With Familial Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1875 - 1880. [Abstract] [Full Text] [PDF]

				T. A. Gresl, R. J. Colman, T. C. Havighurst, D. B. Allison, D. A. Schoeller, and J. W. Kemnitz Dietary Restriction and Beta-Cell Sensitivity to Glucose in Adult Male Rhesus Monkeys J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2003; 58(7): B598 - 610. [Abstract] [Full Text] [PDF]

				F. G. Hamel, J. L. Upward, and R. G. Bennett In Vitro Inhibition of Insulin-Degrading Enzyme by Long-Chain Fatty Acids and Their Coenzyme A Thioesters Endocrinology, June 1, 2003; 144(6): 2404 - 2408. [Abstract] [Full Text] [PDF]

				T. K. T. Lam, A. Carpentier, G. F. Lewis, G. van de Werve, I. G. Fantus, and A. Giacca Mechanisms of the free fatty acid-induced increase in hepatic glucose production Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E863 - E873. [Abstract] [Full Text] [PDF]

				T. K. T. Lam, G. Van de Werve, and A. Giacca Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E281 - E290. [Abstract] [Full Text] [PDF]

				E. Qvigstad, I. L. Mostad, K. S. Bjerve, and V. E. Grill Acute lowering of circulating fatty acids improves insulin secretion in a subset of type 2 diabetes subjects Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E129 - E137. [Abstract] [Full Text] [PDF]

				G. W. Van Citters, M. Kabir, S. P. Kim, S. D. Mittelman, M. K. Dea, P. L. Brubaker, and R. N. Bergman Elevated Glucagon-Like Peptide-1-(7-36)-Amide, but Not Glucose, Associated with Hyperinsulinemic Compensation for Fat Feeding J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5191 - 5198. [Abstract] [Full Text] [PDF]

				T. K. T. Lam, H. Yoshii, C. A. Haber, E. Bogdanovic, L. Lam, I. G. Fantus, and A. Giacca Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E682 - E691. [Abstract] [Full Text] [PDF]

				M. L. Cruz, R. N. Bergman, and M. I. Goran Unique Effect of Visceral Fat on Insulin Sensitivity in Obese Hispanic Children With a Family History of Type 2 Diabetes Diabetes Care, September 1, 2002; 25(9): 1631 - 1636. [Abstract] [Full Text] [PDF]

				R. L. Dobbins, L. S. Szczepaniak, J. Myhill, Y. Tamura, H. Uchino, A. Giacca, and J. D. McGarry The Composition of Dietary Fat Directly Influences Glucose-Stimulated Insulin Secretion in Rats Diabetes, June 1, 2002; 51(6): 1825 - 1833. [Abstract] [Full Text] [PDF]

				G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Endocr. Rev., April 1, 2002; 23(2): 201 - 229. [Abstract] [Full Text] [PDF]

				P. Shah, A. Vella, A. Basu, R. Basu, A. Adkins, W. F. Schwenk, C. M. Johnson, K. S. Nair, M. D. Jensen, and R. A. Rizza Effects of Free Fatty Acids and Glycerol on Splanchnic Glucose Metabolism and Insulin Extraction in Nondiabetic Humans Diabetes, February 1, 2002; 51(2): 301 - 310. [Abstract] [Full Text] [PDF]

				C. Magnan, C. Cruciani, L. Clement, P. Adnot, M. Vincent, M. Kergoat, A. Girard, J.-L. Elghozi, G. Velho, N. Beressi, et al. Glucose-Induced Insulin Hypersecretion in Lipid-Infused Healthy Subjects Is Associated with a Decrease in Plasma Norepinephrine Concentration and Urinary Excretion J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4901 - 4907. [Abstract] [Full Text] [PDF]

				G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, M. Lenzi, A. J. McCullough, S. Natale, G. Forlani, and N. Melchionda Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome Diabetes, August 1, 2001; 50(8): 1844 - 1850. [Abstract] [Full Text] [PDF]

				M.-T. van der Merwe, G. P. Schlaphoff, N. J. Crowther, I. H. Boyd, I. P. Gray, B. I. Joffe, and P. N. Lonnroth Lactate and Glycerol Release from Adipose Tissue in Lean, Obese, and Diabetic Women from South Africa J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3296 - 3303. [Abstract] [Full Text] [PDF]

				G. M. Steil, N. Trivedi, J.-C. Jonas, W. M. Hasenkamp, A. Sharma, S. Bonner-Weir, and G. C. Weir Adaptation of {beta}-cell mass to substrate oversupply: enhanced function with normal gene expression Am J Physiol Endocrinol Metab, May 1, 2001; 280(5): E788 - E796. [Abstract] [Full Text] [PDF]

				C.-P. Liang and A. R. Tall Transcriptional Profiling Reveals Global Defects in Energy Metabolism, Lipoprotein, and Bile Acid Synthesis and Transport with Reversal by Leptin Treatment in Ob/ob Mouse Liver J. Biol. Chem., December 21, 2001; 276(52): 49066 - 49076. [Abstract] [Full Text] [PDF]